Shin Nippon Biomedical Laboratories, Ltd.

Sümbol: 2395.T

JPX

1392

JPY

Turuhind täna

10.3343
P/E suhe
-0.0844
PEG suhe
57.95B
MRK Cap
0.04%
DIV tootlus

Shin Nippon Biomedical Laboratories, Ltd. (2395-T) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Shin Nippon Biomedical Laboratories, Ltd. (2395.T) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Shin Nippon Biomedical Laboratories, Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005
balance-sheet.row.cash-and-short-term-investments	10533.1	6997	7286.5	5249.8	5141.5	5312.7	7447	4942.1	7276.3	9751.8	6787	6717.4	9129.3	10346.7	8926.8	6447.8	7180.7	7696	9000.5
balance-sheet.row.short-term-investments	-423.6	368.1	55.8	-233.7	-220.3	-1044.1	28.3	24.1	-70.1	27.7	-77.3	111.4	1042.2	710.1	404.4	353.3	160.3	1370.8	1295.2
balance-sheet.row.net-receivables	4760.4	3501.6	2954.1	2604.7	1986.8	2708.4	3134.2	3396.1	3449.3	3151.3	2918.7	2650.5	2538.8	2933.5	2737.8	2415.9	2393.7	1616.7	1330.5
balance-sheet.row.inventory	7329.4	4359.4	4071.4	4031.7	3600	6439.5	6965.6	7315.4	7592.9	5365.5	4451.7	6083.9	7481.5	7948.8	7824.1	8218.8	6682.1	5808.3	4438
balance-sheet.row.other-current-assets	1276.7	1276.5	468.1	523.7	938.1	829.6	599.1	652.1	692	481.1	332.1	350.9	410.8	553.5	337.8	358.2	453	432.6	290.3
balance-sheet.row.total-current-assets	23899.6	16134.5	14780	12409.9	11666.4	15290.1	18145.9	16305.7	19010.5	18749.7	14489.5	15802.8	19560.4	21782.5	19826.5	17440.7	16709.5	15553.6	15059.3
balance-sheet.row.property-plant-equipment-net	18879.3	13155.8	12898	13699.7	13686.6	14654.2	17104.6	19893.6	19543.1	19205.1	17097.3	16718.6	17442.4	18409.3	18778.8	17967.2	16048.5	11847.7	8348.3
balance-sheet.row.goodwill	1438.8	0.3	0.8	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	260.7	212	213	194	92	0	371.1	341.6	194.9	206.2	101.7	107.2	157.5	198.9	306.8	327.2	396.2	359.4	332.9
balance-sheet.row.goodwill-and-intangible-assets	1699.4	212.3	213.8	194.4	92.5	288.8	371.1	341.6	194.9	206.2	101.7	107.2	157.5	198.9	306.8	327.2	396.2	359.4	332.9
balance-sheet.row.long-term-investments	12404	8645	8522	12242	27839	27113.8	19045.3	10417.8	1496.5	1273.6	928.7	545.2	-464.2	-301.8	-108.3	907	1075.7	-90.1	-946.8
balance-sheet.row.tax-assets	325.8	1129.6	521.6	1.8	11.4	11.4	15.7	1	63.2	71.2	92.2	239.7	513.8	610.7	323.3	442.7	200.6	173.1	137.7
balance-sheet.row.other-non-current-assets	34.2	35.4	37	454.5	1033	250	1570.3	1281	244	400.1	285.5	497	1438.1	1199.4	987.4	1018.1	822.4	1864.1	1553.6
balance-sheet.row.total-non-current-assets	33342.6	23178.2	22192.4	26592.4	42662.6	42318.3	38107.1	31934.9	21541.8	21156.1	18505.4	18107.6	19087.6	20116.5	20288	20662.1	18543.4	14154.3	9425.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	57242.2	39312.7	36972.4	39002.3	54329	57608.4	56253	48240.6	40552.4	39905.8	32994.9	33910.4	38648	41898.9	40114.5	38102.8	35252.8	29707.8	24484.9
balance-sheet.row.account-payables	419.8	64.6	95	119.3	36.6	84.6	86.7	152.8	73	57.1	105.2	67.3	122.3	199.9	229.9	210.3	166.2	175.5	145.3
balance-sheet.row.short-term-debt	8923.2	2942.7	3486.8	5998.3	11348.2	11523.9	11607.7	10315.7	10679.5	8307.7	9238.2	6381.1	5929.9	5065.2	3494	2270.8	2492.5	1934.9	1930.2
balance-sheet.row.tax-payables	603.7	743.1	683.2	502.3	69.3	182.1	175.9	1405	846.9	789.3	623.1	86.5	57.5	194.2	300.7	559.9	323.9	359.7	195.5
balance-sheet.row.long-term-debt-total	9837.5	6195.6	9199.2	8924.8	4603.2	7409	11298.4	12004.6	11517.2	13394	13481.5	15186.4	15884.8	16924.2	16365.5	11510.6	10174.7	6513.1	8002.2
Deferred Revenue Non Current	-1064	-68.2	-642.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	3009.8	2685.1	2317.4	2033.1	2092.7	2307.1	2045.4	2086	2496.2	2142.6	2295.4	1676.1	1720.7	1861	2667.2	2424.8	2791.9	2015	1518.9
balance-sheet.row.total-non-current-liabilities	9871.5	6215.6	9217.8	9669.3	8083.6	11389.8	14103.7	12269.8	11583	13459.6	13577	15709.4	16031.3	16932.5	16373.9	11523	10289.6	6641.6	8258.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	357	385.8	529.3	707.5	708.5	484.7	492.3	602.5	378.1	448.3	405	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	30883.2	19589.5	21133.6	22620.4	25851.2	31392.7	33779.6	31765.9	30908.4	29390.7	30211.9	29845.3	30782.6	32099.1	30835.8	25144.5	22788.8	17895.3	17776
balance-sheet.row.preferred-stock	0	2620.8	105.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	9679.1	9679.1	9679.1	9679.1	9679.1	9679.1	9679.1	9061.5	9061.5	9061.5	5391.1	5391.1	5391.1	5391.1	5391.1	5391.1	5391.1	5391.1	3352.7
balance-sheet.row.retained-earnings	13766.2	10196.3	3854.5	-2489	-10082.6	-12059	-8260.3	-7331.9	-7587.4	-6201.6	-5446.6	-4293.8	-886.6	1005.2	571.1	982.7	485.9	45.2	-144
balance-sheet.row.accumulated-other-comprehensive-income-loss	460.2	-2620.8	-105.7	3901.4	18450.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	2306.4	-314.3	2200.9	5196.6	10362.3	28538.6	21032.5	14717.4	8142.6	7573.1	2770.4	2909.2	3302.1	3331.4	3246.6	6498.3	6504.3	6380.8	3503.6
balance-sheet.row.total-stockholders-equity	26211.8	19561.1	15734.5	16288.1	28409	26158.7	22451.3	16447	9616.7	10433	2714.8	4006.5	7806.5	9727.7	9208.8	12872.1	12381.2	11817	6712.3
balance-sheet.row.total-liabilities-and-stockholders-equity	57242.2	39312.7	36972.4	39002.3	54329	57608.4	56253	48240.6	40552.4	39905.8	32994.9	33910.4	38648	41898.9	40114.5	38102.8	35252.8	29707.8	24484.9
balance-sheet.row.minority-interest	147.2	162	104.3	93.8	68.8	57	22.1	27.8	27.2	82.2	68.2	58.7	58.9	72.1	70	86.2	82.8	-4.5	-3.3
balance-sheet.row.total-equity	26359	19723.1	15838.8	16381.8	28477.8	26215.7	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	11980.4	7080.1	8286.9	12008.3	27618.7	26069.8	19073.7	10441.9	1426.4	1301.3	851.4	656.6	578	408.3	296.1	1260.2	1236	1280.6	348.5
balance-sheet.row.total-debt	18760.7	9138.3	12686.1	14923.1	15951.4	18932.8	22906.1	22320.4	22196.7	21701.7	22719.7	21567.6	21814.7	21989.4	19859.5	13781.4	12667.2	8448	9932.4
balance-sheet.row.net-debt	8227.6	2509.4	5455.3	9673.2	10809.9	13620.1	15487.4	17402.3	14920.4	11977.6	15932.7	14961.6	13727.6	12352.8	11337.1	7686.9	5646.8	2122.8	2227.2

Rahavoogude aruanne

Shin Nippon Biomedical Laboratories, Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005
cash-flows.row.net-income	7759.6	8183.3	4175.6	3062.7	1650.7	-1508	-764.7	3550.3	-398.5	95.5	-511.2	-2861.9	-1138.9	411	199.6	856.1	975.9	575.1	-491.2
cash-flows.row.depreciation-and-amortization	1600.5	1177.4	1187.7	1229.2	1361.6	1472.8	1545.8	1592.1	1391.9	1318.4	1374.7	1592.9	1763.4	1938.4	1831.4	1819.5	1304.7	919.9	837
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-236.4	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36.2	0
cash-flows.row.change-in-working-capital	-2812.9	723.3	532	-907.3	1276.9	955.5	551.5	375.8	-1735.8	-847.8	-14.8	135.4	-421.1	-224.2	-422.8	106.5	-1648.2	-605.4	810.7
cash-flows.row.account-receivables	-937	-480	-343	-619	-149	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-968.5	-371.1	-71.7	-445.3	-424.5	398.3	-70.7	-500.9	-1694.8	-559.8	1833.6	1218.2	-84.3	-73.5	-602.3	-1675.2	-793.9	-1055.6	327.3
cash-flows.row.account-payables	-268.2	-36.7	-24.2	82.7	119.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-639.2	1611.1	970.8	74.3	1731.2	557.2	622.2	876.7	-40.9	-288	-1848.4	-1082.7	-336.8	-150.7	179.5	1781.6	-854.4	450.2	483.3
cash-flows.row.other-non-cash-items	-2543.2	-4131.3	-1148.5	-366.2	-1396.5	423.9	-2182.5	-8858.1	-1413.7	-2186.2	-758.3	100.4	103.4	-381.7	-739.5	384.3	-183.6	65.6	-92.8
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-4955.7	-1614.3	-1118	-1230.1	-1099.8	-1018.3	-1015.9	-1808.2	-1468.7	-1745.7	-810.8	-895.7	-957.9	-2158.5	-4070.8	-4671.5	-4927.5	-3968.9	-2029.6
cash-flows.row.acquisitions-net	-1937.2	1200.8	1242.3	-4.6	1500.7	1815.5	91.5	3529.8	84.4	-186.3	0	49.2	-44.5	-42.8	-130.4	0	-106.6	0	-199.9
cash-flows.row.purchases-of-investments	-1514.3	-4194.1	-895	-790.4	-9	-18.6	-1	-55.8	-208.4	-340.1	-109.1	-191.7	-204.8	-215.2	-1026.4	-158.2	-80	-995.1	-245.1
cash-flows.row.sales-maturities-of-investments	2532.2	266.7	91.4	496.7	20.3	19.3	509	552.2	17.1	355.3	154	2	133	210.1	1947.2	0	116.4	0	27.3
cash-flows.row.other-investing-activites	-55.5	72.3	410.6	73.3	22.5	39.9	102.2	-932	482.8	144.3	15.7	29.1	224.7	34.4	477.8	14.4	950.7	184.5	2093.1
cash-flows.row.net-cash-used-for-investing-activites	-5930.6	-4268.5	-268.7	-1455.1	434.8	837.8	-314.2	1286	-1092.8	-1772.6	-750.3	-1007.1	-849.5	-2172.1	-2802.6	-4815.3	-4047	-4779.6	-354.2
cash-flows.row.debt-repayment	-5468.1	-3492.3	-4598.2	-4166.9	-4707.5	-5892.7	-6657.7	-6650.2	-6707.8	-7199.5	-5781.8	-4952	-4258.3	-3679.3	-2293.1	-2378	-2160.8	-1880.4	-1067.7
cash-flows.row.common-stock-issued	0.2	0	0	0	0	0	1227.8	0	7198.7	7218.6	16.9	0.2	517.4	0.2	8429.7	0	0	4040.6	0
cash-flows.row.common-stock-repurchased	-0.2	0	0	0	0	-16.6	0	0	0	6043.7	6437.7	0	0	-190.6	-672.8	0	0	378.8	0
cash-flows.row.dividends-paid	-2484.4	-826.5	-206.2	-123.6	0	0	0	0	0	-1.2	-1.2	-103.7	-98.5	-102.6	-203.3	-102.2	-102.1	-77.9	-93.2
cash-flows.row.other-financing-activites	14218.8	-593.1	2333.4	2840.9	1205.9	1684.9	9245	6368	15.8	77.1	0	4676.4	3496.5	5805.2	-10.5	3489.5	6348.4	9.8	5924.1
cash-flows.row.net-cash-used-provided-by-financing-activities	6266.2	-4912	-2471.1	-1449.6	-3501.6	-4224.3	3815.1	-282.2	506.7	6138.7	671.6	-379.1	-343	1833	5250	1009.3	4085.5	2470.8	4763.2
cash-flows.row.effect-of-forex-changes-on-cash	311.5	496.7	29.6	-5.1	14.9	-87.5	-152.9	9.3	265.9	372.6	168.6	-79.8	-267.8	13.6	-594.3	-91.4	28.6	400.2	-115.2
cash-flows.row.net-change-in-cash	4648.9	-2731	2036.6	108.5	-159.3	-2129.7	2498.2	-2326.8	-2476.2	2977.4	180.3	-2499.2	-1153.5	1418.1	2721.8	-731	515.7	-1153.6	5573.3
cash-flows.row.cash-at-end-of-period	9197.7	4548.8	7279.8	5243.3	5134.7	5294.1	7423.8	4925.6	7252.5	9728.7	6751.2	6570.9	9070.1	10223.6	8805.5	6083.7	6814.7	6299	7452.5
cash-flows.row.cash-at-beginning-of-period	4548.8	7279.8	5243.3	5134.7	5294.1	7423.8	4925.6	7252.5	9728.7	6751.2	6570.9	9070.1	10223.6	8805.5	6083.7	6814.7	6299	7452.5	1879.2
cash-flows.row.operating-cash-flow	4004	5952.8	4746.7	3018.3	2892.7	1344.3	-849.8	-3339.9	-2156	-1620.1	90.3	-1033.2	306.8	1743.6	868.7	3166.4	448.7	755.1	1063.6
cash-flows.row.capital-expenditure	-4955.7	-1614.3	-1118	-1230.1	-1099.8	-1018.3	-1015.9	-1808.2	-1468.7	-1745.7	-810.8	-895.7	-957.9	-2158.5	-4070.8	-4671.5	-4927.5	-3968.9	-2029.6
cash-flows.row.free-cash-flow	-951.7	4338.5	3628.7	1788.1	1792.9	326	-1865.7	-5148.1	-3624.8	-3365.8	-720.5	-1928.9	-651.1	-414.9	-3202.1	-1505.1	-4478.8	-3213.9	-966

Kasumiaruande rida

Shin Nippon Biomedical Laboratories, Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 2395.T brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005
income-statement-row.row.total-revenue	25090.9	17748.5	15110.5	14561.1	15658.7	16600.5	17244.5	14750.1	17835	16926.4	17154.1	15274	17371.9	19050.3	19540.2	19647.2	17289.4	13805.4	12295.7
income-statement-row.row.cost-of-revenue	12044.2	8061.2	7556.1	6945.4	9480.9	11396.4	12884.2	12059.1	11882.6	11178.2	12467.2	11978.1	12149.3	12825.3	12703.1	11958.4	10590.1	8417	8261.2
income-statement-row.row.gross-profit	13046.7	9687.3	7554.4	7615.7	6177.8	5204.1	4360.2	2691	5952.4	5748.2	4686.8	3295.8	5222.6	6225	6837.1	7688.8	6699.3	5388.4	4034.6
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	15.2	191.1	211.4	119.7	97.5	38.9	-69.8	168.5	162.4	170.5	195	486.2	389.8	542.1	229.5	176.1	30	-20.3	14.6
income-statement-row.row.operating-expenses	7801.4	5491.7	5024.9	5387.5	5348	5901.6	6152.7	6554.4	6588.7	6471.9	6114.9	5563.1	5301.5	5125.1	5523.2	5146.6	4832.2	4003.4	3759.1
income-statement-row.row.cost-and-expenses	19845.7	13552.9	12581	12332.8	14828.9	17298	19037	18613.5	18471.3	17650.2	18582.1	17541.2	17450.8	17950.4	18226.2	17105	15422.4	12420.4	12020.3
income-statement-row.row.interest-income	57.4	8.3	3	9.3	18.5	9.1	15.1	15.2	4	8.2	4.9	9.5	9.4	12.9	45.5	46.5	58.8	58.5	9.3
income-statement-row.row.interest-expense	125.1	126.6	184.9	235	377.8	374	378.1	304.3	289.9	307.5	302.3	309.3	343.4	342.7	283.8	251.6	177.6	177.9	150
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	2514	3986	1644	832	890	-810.5	1027.8	7413.8	237.8	819.3	916.8	-594.7	-1060.1	-688.9	-1114.4	-1686.1	-891.2	-809.9	-766.6
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	15.2	191.1	211.4	119.7	97.5	38.9	-69.8	168.5	162.4	170.5	195	486.2	389.8	542.1	229.5	176.1	30	-20.3	14.6
income-statement-row.row.total-operating-expenses	2514	3986	1644	832	890	-810.5	1027.8	7413.8	237.8	819.3	916.8	-594.7	-1060.1	-688.9	-1114.4	-1686.1	-891.2	-809.9	-766.6
income-statement-row.row.interest-expense	125.1	126.6	184.9	235	377.8	374	378.1	304.3	289.9	307.5	302.3	309.3	343.4	342.7	283.8	251.6	177.6	177.9	150
income-statement-row.row.depreciation-and-amortization	1600.5	1177.4	1187.7	1229.2	1361.6	1472.8	1545.8	1592.1	1391.9	1318.4	1374.7	1592.9	1763.4	1938.4	1831.4	1819.5	1304.7	919.9	837
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	5245.2	4195.6	2529.5	2228.3	829.8	-697.5	-1792.5	-3863.4	-636.3	-723.8	-1428.1	-3048.9	-843.7	343.8	463.9	1585.6	1125.8	772.2	-329
income-statement-row.row.income-before-tax	7759.6	8183.3	4175.6	3062.7	1650.7	-1508	-764.7	3550.3	-398.5	95.5	-511.2	-2861.9	-1138.9	411	199.6	856.1	975.9	575.1	-491.2
income-statement-row.row.income-tax-expense	1708.9	1016.2	497.8	414.5	-308.1	2013.2	127.8	903.4	992.4	857.6	651.4	443.1	314.4	-116.6	412.7	264.1	433.6	309.4	-17
income-statement-row.row.net-income	6060.1	7127.6	3661.9	2550.4	1950.3	-3555.9	-915.9	2646.1	-1385.7	-755	-1152.9	-3304.1	-1442	534.5	-205.5	599.9	543.8	267.4	-472.4